LH - Laboratory Corporation of America Holdings

NYSE - NYSE Delayed Price. Currency in USD

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336-229-1127
http://www.labcorp.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees61,000

Key Executives

NameTitlePayExercisedYear Born
Mr. David P. KingChairman, CEO & Pres2.95M12.57M1956
Mr. Glenn A. EisenbergCFO & Exec. VP1.36MN/A1961
Mr. F. Samuel Eberts IIIChief Legal Officer, Chief Compliance Officer, Sr. VP & Sec.N/AN/A1960
Mr. John D. RatliffChief Exec. Officer of Covance Drug Devel.1.63MN/A1960
Dr. Michelle AbelsonLaboratory Director of OperationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides technology-enabled solutions, including a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with convenient and secure access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Corporate Governance

Laboratory Corporation of America Holdings’s ISS Governance QualityScore as of April 1, 2019 is 2. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.